Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200015/S076

Edwards SAPIEN 3 Transcatheter Pulmonary Valve (TPV) System with Alterra Adaptive Prestent

Edwards Lifesciences, LLC · Decision date Jun 4, 2026

FDA DECISIONP200015/S076

What did the FDA approve?

FDA records P200015/S076 as a supplement to PMA P200015, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 4, 2026.

FDA approval order statement

Approval for an update to the Magnetic Resonance (MR) Conditional statement in the labeling for the Edwards Alterra Adaptive Prestent.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Jun 4, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P200015/S076
Regulatory pathway
PMA supplement
Product code
NPV
Decision code
APPR
Decision date
Jun 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulmonary valve prosthesis percutaneously delivered.

Product code
NPV
FDA device class
f

For the original device and its historical approval scope, see PMA P200015. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200015 · Original PMA

    Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System

  2. P200015/S070 · Related supplement

    Edwards Commander Delivery System: 9600LDS23, 9600LDS26, 9600LDS29 9750CM23, 9750CM26, 9750CM29

  3. P200015/S071 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve

  4. P200015/S068 · Related supplement

    Edwards SAPIEN 3 Transcatheter Pulmonic Valve Delivery System

  5. P200015/S073 · Related supplement

    Edwards Commander Delivery System (9600LDS20, 9600LDS23 9600LDS26, 9600LDS29)

  6. P200015/S074 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System

  7. P200015/S076 received

    Application receipt date recorded by FDA.

  8. P200015/S075 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve

  9. P200015/S072 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System

  10. P200015/S076 · FDA decision

    Real-Time Process

  11. P200015/S078 · Related supplement

    Edwards Commander Delivery System (9600LDS20; 9600LDS23; 9600LDS26; 9600LDS29)

  12. P200015/S079 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve

  13. P200015/S069 · Related supplement

    Edwards SAPIEN 3 Pulmonic Delivery System: 9630PL29

  14. P200015/S080 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX20; 9600TFX23; 9600TFX26; 9600TFX29)

  15. P200015/S081 · Related supplement

    Edwards SAPIEN 3 Pulmonic Delivery System (9630PL29); Edwards Alterra Adaptive Prestent System (29AP4045)

  16. P200015/S083 · Related supplement

    Edwards Crimper (9600LDS20, 9600LDS23, 9600LDS26, 9600LDS29)

  17. P200015/S077 · Related supplement

    SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive Prestent

  18. P200015/S084 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX)

Timeline entries are records held by MedtechLedger for P200015. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200015

Product / regulatory recordCompanyPathwayDecision dateSource
Edwards Lifesciences, LLCPMA approvalAug 31, 2020FDA
Edwards Lifesciences, LLCPMA supplementOct 2, 2025FDA
Edwards Lifesciences, LLCPMA supplementOct 16, 2025FDA
Edwards Lifesciences, LLCPMA supplementJan 28, 2026FDA
Edwards Lifesciences, LLCPMA supplementFeb 12, 2026FDA
Edwards Lifesciences, LLCPMA supplementFeb 27, 2026FDA
Edwards Lifesciences, LLCPMA supplementMar 11, 2026FDA
Edwards Lifesciences, LLCPMA supplementApr 9, 2026FDA
Edwards Lifesciences, LLCPMA supplementJun 30, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 2, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 17, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 28, 2026FDA
Edwards Lifesciences, LLCPMA supplementJul 29, 2026FDA
Edwards Lifesciences, LLCPMA supplementSep 23, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 27, 2026FDA
Edwards Lifesciences, LLCPMA supplementOct 28, 2026FDA

Explore the linked device profile

Other records with product code NPV

Product / regulatory recordCompanyPathwayDecision dateSource
Harmony TPV SystemP200046/S052
Medtronic, Inc.PMA supplementSep 30, 2026FDA
Medtronic, Inc.PMA supplementJun 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records